Natalie Posever
Natalie Posever
Sanjit S Jolly,Marc-André d&#x;Entremont,Bertram Pitt et al.
Sanjit S Jolly et al.
Background: Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial after myoca...
NEJM at AHA - CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy [0.03%]
NEJM在AHA上的报道-用于ATTR性心肌病的Nexigeran Ziclumeran nexiguran ziclumeran CRISPR-Cas9基因编辑疗法
Eric J Rubin,Jane Leopold,Stephen Morrissey
Eric J Rubin
NEJM at AHA - Intensive Blood-Pressure Control in Patients with Type 2 Diabetes [0.03%]
NEJM特刊（AHA会议专刊）——糖尿病患者血压的强化控制
Eric J Rubin,Jane Leopold,Stephen Morrissey
Eric J Rubin
NEJM at AHA - Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity [0.03%]
NEJM 心脏衰竭会议 | Tirzepatide 治疗射血分数保留型心力衰竭和肥胖症
Eric J Rubin,Jane Leopold,Stephen Morrissey
Eric J Rubin
NEJM at AHA - Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease [0.03%]
NEJM述评AHA会议——AAV9-LAMP2B基因治疗Danon病的Ⅰ期研究
Eric J Rubin,Jane Leopold,Stephen Morrissey
Eric J Rubin
NEJM at AHA - Left Atrial Appendage Closure after Ablation for Atrial Fibrillation [0.03%]
NEJM述评：房颤射频消融术后左心耳封堵术
Eric J Rubin,Jane Leopold,Stephen Morrissey
Eric J Rubin
NEJM at AHA - Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia [0.03%]
NEJM述评：心室性心动过速的导管消融术与抗心律失常药物治疗
Eric J Rubin,Jane Leopold,Stephen Morrissey
Eric J Rubin
NEJM at AHA - Routine Spironolactone in Acute Myocardial Infarction [0.03%]
新英格兰医学杂志在美国心脏协会年会上发布万华医药最新研究成果ertosartan治疗急性心肌梗死患者的疗效及安全性研究
Eric J Rubin,Jane Leopold,Stephen Morrissey
Eric J Rubin
John H Stone,Arezou Khosroshahi,Wen Zhang et al.
John H Stone et al.
Background: IgG4-related disease is a multiorgan, relapsing, fibroinflammatory, immune-mediated disorder with no approved therapy. Inebilizumab targets and depletes CD19+ B cells and may be effective for treating patients...